Features of Heart Failure with Preserved Ejection Fraction in Patients with Chronic Obstructive Pulmonary Disease and Systemic Sclerosis-Associated Interstitial Lung Diseases
Merkmale der Herzinsuffizienz mit erhaltener Ejektionsfraktion bei Patient:innen mit chronisch obstruktiver Lungenerkrankung und systemischer Sklerose-assoziierten interstitiellen Lungenerkrankungen
Journal of Personalized Medicine · 20.05.2025 · 15 (5) · 206
DOI: 10.3390/jpm15050206 ↗Auf einen Blick
Bei 150 Patient:innen mit chronischen Lungenerkrankungen waren bei HFpEF bestimmte kardiale und Laborparameter erhöht. Die Autor:innen beschreiben unterschiedliche HFpEF-Phänotypen bei COPD und SS-ILD.
Fragestellung
Unterscheidet sich die Entstehung von HFpEF bei Patient:innen mit COPD und SS-ILD und welche Phänotypen lassen sich erkennen?
Methode
150 Patient:innen mit COPD oder SS-ILD außerhalb einer Exazerbation, ohne chronische Herzinsuffizienz und mit LV-EF ≥50 %; Vergleich mit und ohne HFpEF nach HFA-PEFF; nichtparametrische Statistik.
Ergebnisse
Bei CLD waren Alter, longitudinale Größe des rechten Vorhofs, MR-proANP und hsTnT bei HFpEF höher. Bei COPD mit HFpEF war das linksatriale Volumen verändert, bei SS-ILD mit HFpEF u. a. SBP, Borg-Score, MR-proANP und rechter Vorhof.
Schlussfolgerung der Autor:innen
Die Autor:innen sehen zwei unterschiedliche Mechanismen der HFpEF-Entwicklung: bei COPD vor allem Hypoxie, bei SS-ILD myokardiale Dysfunktion mit Remodeling bei sekundärer pulmonaler Hypertonie.
Kernaussagen
- HFpEF war mit höheren Werten von MR-proANP und hsTnT assoziiert
- Bei COPD standen Veränderungen des linksatrialen Volumens im Vordergrund
- Bei SS-ILD zeigten sich Unterschiede u. a. bei SBP, Borg-Score und rechtem Vorhof
Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.
Kurz gefasst
Fachartikel in der Zeitschrift Journal of Personalized Medicine, online erschienen am 20.05.2025. Verfasst von Lyazat Ibrayeva und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Karaganda Medical University, Karaganda 100012, Kazakhstan. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Science and Higher Education of the Republic of Kazakhstan, Ministry of Science and Higher Education of the Republic of Kazakhstan, “Pathogenetic Significance of Structural and Functional Imbalance of the Vascular Syste….
Themen: COPD, Herzinsuffizienz
Abstract (Originalsprache)
Background/Objectives: This study aims to investigate the potential etiopathogenesis of HFpEF development and identify possible different phenotypes of HFpEF in patients with chronic obstructive pulmonary disease (COPD) and systemic sclerosis-associated interstitial lung diseases (SS-ILDs). It could help clinicians improve early HFpEF personalized detection and management.
Methods
This study included 150 patients with chronic lung diseases (CLDs), such as COPD and SS-ILD, who were outside of exacerbation, had no history of chronic heart failure (CHF), and had a left ventricular ejection fraction (LV EF) of ≥50%. The functional status of the lungs, heart, endothelial dysfunction, and acid–base balance was assessed. The results obtained were compared in groups of patients with CLD depending on the presence or absence of HF with preserved ejection fraction (HFpEF). The diagnosis of HFpEF was established based on the HFA-PEFF Score classification. Nonparametric statistical methods were used.
Results
In patients with CLD, indicators such as age, longitudinal size of the right atrium, mid-regional pro-atrial natriuretic peptide (MR-proANP), and highly sensitive cardiac troponin T (hsTnT) were higher than in the group of patients without HFpEF. In patients with COPD and HFpEF, statistically significant changes were found in the volume of the left atrium. In patients with SS-ILD and HFpEF, statistically significant differenceswere found in SBP before and after the 6 min walk test (6MWT), the Borg scale before 6MWT, MR-proANP, and the longitudinal dimension of the right atrium.
Conclusions
The results of our study allow us to identify two different mechanisms of HFpEF development: In patients with COPD, the predominant factor in the development of HFpEF was hypoxia, while in patients with SS-ILD, myocardial dysfunction with remodeling developed against the background of secondary pulmonary hypertension, highlighting the importance of phenotype-specific evaluation. These findings suggest potential approaches for personalized risk stratification and the development of targeted management strategies for patients with HFpEF.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Internal Medicine, Karaganda Medical University, Karaganda 100012, Kazakhstan.
- Administration Department, Regional Clinical Hospital of Karaganda, Karaganda 100000, Kazakhstan.
- Scientific Research Laboratory, Karaganda Medical University, Karaganda 100012, Kazakhstan.
ORCID-Profile: Lyazat Ibrayeva, Meruyert Aubakirova, Irina Bacheva, Assel Alina, Nazira Bazarova, Aizhan Zhanabayeva
Förderung
- Ministry of Science and Higher Education of the Republic of Kazakhstan
- Ministry of Science and Higher Education of the Republic of Kazakhstan, “Pathogenetic Significance of Structural and Functional Imbalance of the Vascular Syste…
Zitieren
APA
Ibrayeva, L., Aubakirova, M., Bacheva, I., Alina, A., Bazarova, N., Zhanabayeva, A., Avdiyenko, O., Borchashvili, S., Tazhikhanova, S., & Murzabaeyev, A. (2025). Features of Heart Failure with Preserved Ejection Fraction in Patients with Chronic Obstructive Pulmonary Disease and Systemic Sclerosis-Associated Interstitial Lung Diseases. Journal of Personalized Medicine, 15(5), 206. https://doi.org/10.3390/jpm15050206
Vancouver
Ibrayeva L, Aubakirova M, Bacheva I, Alina A, Bazarova N, Zhanabayeva A, et al. Features of Heart Failure with Preserved Ejection Fraction in Patients with Chronic Obstructive Pulmonary Disease and Systemic Sclerosis-Associated Interstitial Lung Diseases. Journal of Personalized Medicine. 2025;15(5):206. doi:10.3390/jpm15050206
BibTeX
@article{Ibrayeva2025,
author = {Ibrayeva, Lyazat and Aubakirova, Meruyert and Bacheva, Irina and Alina, Assel and Bazarova, Nazira and Zhanabayeva, Aizhan and Avdiyenko, Olga and Borchashvili, Seda and Tazhikhanova, Saltanat and Murzabaeyev, Askhat},
title = {Features of Heart Failure with Preserved Ejection Fraction in Patients with Chronic Obstructive Pulmonary Disease and Systemic Sclerosis-Associated Interstitial Lung Diseases},
journal = {Journal of Personalized Medicine},
year = {2025},
volume = {15},
number = {5},
pages = {206},
doi = {10.3390/jpm15050206}
}
EUVIMED